Balancing the risks and benefits for pioglitazone in type 2 diabetes

被引：4
作者：
Johnson, Jeffrey A. [1 ]
Colmers, Isabelle N. [1 ]
机构：
[1] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2012年 / 98卷 / 01期
关键词：
BLADDER-CANCER;
D O I：
10.1016/j.diabres.2012.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 13 条
[1]   Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people [J].
Andersson, Charlotte ;
Vaag, Allan ;
Selmer, Christian ;
Schmiegelow, Michelle ;
Sorensen, Rikke ;
Lindhardsen, Jesper ;
Gislason, Gunnar H. ;
Kober, Lars ;
Torp-Pedersen, Christian .
BMJ OPEN, 2012, 2 (03)
[2]  
[Anonymous], CMAJ
[3]   The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study [J].
Azoulay, Laurent ;
Yin, Hui ;
Filion, Kristian B. ;
Assayag, Jonathan ;
Majdan, Agnieszka ;
Pollak, Michael N. ;
Suissa, Samy .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[4]   Cancer occurrence in Danish diabetic patients: duration and insulin effects [J].
Carstensen, B. ;
Witte, D. R. ;
Friis, S. .
DIABETOLOGIA, 2012, 55 (04) :948-958
[5]  
Colmers IN, DIABETES ME IN PRESS
[6]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[7]   Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias [J].
Johnson, J. A. ;
Bowker, S. L. ;
Richardson, K. ;
Marra, C. A. .
DIABETOLOGIA, 2011, 54 (09) :2263-2271
[8]   Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study [J].
Lewis, James D. ;
Ferrara, Assiamira ;
Peng, Tiffany ;
Hedderson, Monique ;
Bilker, Warren B. ;
Quesenberry, Charles P., Jr. ;
Vaughn, David J. ;
Nessel, Lisa ;
Selby, Joseph ;
Strom, Brian L. .
DIABETES CARE, 2011, 34 (04) :916-922
[9]   Pioglitazone inhibits platelet function and potentiates the effects of aspirin: A prospective observation study [J].
Mongan, John ;
Mieszczanska, Hanna Z. ;
Smith, Brian H. ;
Messing, Susan P. ;
Phipps, Richard P. ;
Francis, Charles W. .
THROMBOSIS RESEARCH, 2012, 129 (06) :760-764
[10]   Screening for Bladder Cancer: US Preventive Services Task Force Recommendation Statement [J].
Moyer, Virginia A. .
ANNALS OF INTERNAL MEDICINE, 2011, 155 (04) :246-+
12